ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like Study highlights global fertility decline and its implications for the future March 21, 2024 Lung cancer screening yields early diagnoses and increased cure rates in veterans June 10, 2024 Research uncovers link between reproductive factors and COPD risk in women February 14, 2024